Neuropediatry

Clinical Trails

Results of a multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of Mexidol in the treatment of attention deficit hyperactivity disorder in children (MEGA) Link to study status here

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of atherosclerotic stenizing lesions of the brachiocephalous arteries in the formation of cognitive impairment

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of atherosclerotic stenizing lesions of the brachiocephalous arteries in the formation of cognitive impairment

Attention Deficit Hyperactivity Disorder - Clinical Manifestations from Child to Adult

Authors:
L. S. Chutko, Professor, Doctor of Medical Sciences, Head of the Laboratory of Correction of Mental Development and Adaptation, Head of the Center for Behavioral Neurology of the N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, Professor of the Department of Family Medicine of the Faculty of Preparatory and Continuing Professional Education of the Federal State Budgetary Educational Institution of Higher Education St. Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation, St. Petersburg, Russia

E. A. Yakovenko, Ph.D., researcher at the Institute of the Human Brain named after. N.P. Bekhtereva Russian Academy of Sciences, St. Petersburg, Russia

S. Yu. Surushkina, neurologist, PhD, research fellow at the N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, St. Petersburg, Russia

The possibility of using Mexidol in neuropediatrics

Authors:
N.N. Zavadenko, N.Yu. Suvorinova, A.N. Zavadenko

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Results of a multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of Mexidol in the treatment of attention deficit hyperactivity disorder in children (MEGA) Link to study status here

Link to the status of the study here

N.N. ZAVADENKO ¹ , N.Yu. SUVORINOVA ¹ , T.T. BATYSHEVA ² , O.V. BYKOVA ² , A.N. PLATONOVA ² , D.D. GAYNETDINOVA ³ , E.V. LEVITINA ⁴ , V.V. MASHIN ⁵ , I.N. VAKULA ⁶ , N.E. MAKSIMOVA ⁷

¹ FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² GBUZ "Scientific and practical center of children's psychoneurology of the Department of Health of Moscow", Moscow, Russia;
³ FSBEI in Kazan State Medical University of the Ministry of Health of Russia, Kazan, Russia;
⁴ FSBEI in Tyumen State Medical University of the Ministry of Health of Russia, Tyumen, Russia;
⁵ FSBEI in Ulyanovsk State University, Ulyanovsk, Russia;
⁶ LLC "Center for Professional Therapy", Krasnodar, Russia;

⁷FSBEI in the Tver State Medical University, Tver, Russia

Place of publication:
a journal of neurology and psychiatry named after S.S. Korsakova, 2022, T.122, No. 4

Experience in the use of Mexidol® in children and adolescents with mental disorders

Authors:
Yu.Sh. Vasyanina

The use of Mexidol® in children's neurological practice

Authors:
G.R. Khamitova

The use of Mexidol in the correction of vegetative dizregulation syndrome as the consequences of perinatal lesions of the central nervous system

Authors:
M.A. Okuneva

The course of school adaptation in children with syndrome of attention deficiency with hyperactivity against the background of the use of Mexidol

Authors:
I.S. Potapova, N.V. Khrina, M.V. Protopopova

Library

Clinical Trails

Neuropediatry

Attention Deficit Hyperactivity Disorder - Clinical Manifestations from Child to Adult

The possibility of using Mexidol in neuropediatrics

Results of a multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of Mexidol in the treatment of attention deficit hyperactivity disorder in children (MEGA) Link to study status here

Experience in the use of Mexidol® in children and adolescents with mental disorders

The use of Mexidol® in children's neurological practice

The use of Mexidol in the correction of vegetative dizregulation syndrome as the consequences of perinatal lesions of the central nervous system

The course of school adaptation in children with syndrome of attention deficiency with hyperactivity against the background of the use of Mexidol